NAT10 and Hutchinson-Gilford progeria syndrome: The enzyme, NAT10, is responsible for the incorporation of an acetyl moiety on the fourth position of cytidine (Supplementary Fig. S10) and has been identified as a potential target for the treatment of diseases such as cancer [56], Hutchinson-Gilford Progeria Syndrome [57], and osteoporosis [41].